HCP Resources

Resources for you and your practice

RYBREVANT FASPRO resources

Administration &
Management Guide

Comprehensive dosing, administration, and proactive therapy management details for RYBREVANT FASPRO.

RYBREVANT® (amivantamab-vmjw) resources

Administration &
Management Guide

Comprehensive dosing, administration, and proactive therapy management details for RYBREVANT®.


Access Resources

Access resources for you and your practice

Access & Reimbursement
Guide

A helpful guide to navigating access for RYBREVANT FASPRO–based regimens.

Billing & Coding
Guide

An explanation for office staff about insurance codes and billing for RYBREVANT FASPRO–based regimens.

Where to Order Flashcard

A flashcard on how to order RYBREVANT FASPRO™ + LAZCLUZE® (lazertinib) for your patients.

Overview of J&J withMe
Support Resources

A comprehensive overview of access, affordability, and treatment support available through J&J withMe.

J&J withMe Delay and
Denial Support

A resource that provides a detailed guide on how to get support in the event of a coverage delay or denial for your commercially insured patients.


Patient Resources

Resources for your patients

Download to support your patients with their treatment experience.

Patient Treatment
Brochure

A general guide for patients receiving RYBREVANT FASPRO–based and RYBREVANT®-based treatments.

Patient Treatment
Experience Tips
Flashcard

A resource to help your patients take care of themselves while on treatment with a RYBREVANT FASPRO™–based or RYBREVANT®-based regimen.

Patient Treatment
Journal

A notebook designed for a patient to track their treatment plan and journey.

Patient Wallet Card

Streamlined treatment information card for patients on the go.

Patient Affordability
Options

A resource to help your patients learn about cost support options for their RYBREVANT FASPRO–based or RYBREVANT®-based regimen.

J&J withMe Patient
Support Program

J&J withMe provides your patients with free, personalized support throughout their cancer treatment journey. Download this resource to learn more.


J&J withMe logo

Once you have made the clinical decision to prescribe a RYBREVANT FASPRO–based or RYBREVANT®-based regimen, Johnson & Johnson has resources to help you support your patients.

Comprehensive Support Throughout Your Patients' Treatment Journey

J&J withMe is your single source for access, affordability, and treatment support programs from Johnson & Johnson. Your patients will be connected to RYBREVANT withMe.

For Your Office

J&J withMe provides your office with educational support to help patients throughout their treatment journey on RYBREVANT FASPRO or RYBREVANT®.

  • Access and Affordability Support:
  • Benefits investigation support
  • Prior authorization support and status monitoring
  • Information on the exceptions and appeals process
  • Coding and billing information
  • Finding cost support options for eligible patients
  • Dedicated support from a Field Reimbursement Manager:
  • Access, fulfillment, and reimbursement education
  • Information on cost support options for eligible patients
  • Ability to connect with a specialty pharmacy in case of fulfillment issues

For Your Patients

Your patients will be connected with RYBREVANT withMe, the program that aligns with the J&J medicine they have been prescribed. Support includes:

  • Cost support: J&J withMe Savings Program and other resources
  • Free, personalized 1-on-1 Care Navigator Support
  • Resources and community connections

Get started with J&J withMe:

  • Visit Portal.JNJwithMe.com to investigate insurance coverage for your patients, enroll your patients in savings, or sign them up for Care Navigator support
  • Visit JNJwithMe.com/hcp/RYBREVANT for access and affordability information for the J&J medicine you prescribed
  • Bookmark these links for quick and easy access!
  • Questions? Call 833-JNJ-wMe1 (833-565-9631), Monday through Friday, 8:00 AM to 8:00 PM ET

The patient support and resources provided by J&J withMe are not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe RYBREVANT FASPRO or RYBREVANT®.